PFE and MRK Related Headlines
Go Back- Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
- This stock is a new preferred major pharma pick at Citi
- Pfizer (PFE) and Illumina (ILMN) downgraded but Merck (MRK) can deliver, declares TD Cowen
- Citi sees attractive buying opportunity in this beaten-down big pharma stock
- 2 pharma stocks to own - UBS
- HHS Names 10 Drugs Subject To Medicare Price Negotiations
- Eli Lilly's (LLY) strong Q2 market cap growth driven by diabetes drug Mounjaro - GlobalData
- Stock market today: Dow edged higher but S&P stumbled after deluge of earnings
- Qualcomm earnings, Shopify reports, CVS Health: 3 things to watch
- S&P 500 stumbles pressured by cruise stocks as earnings season heats up
- U.S. stocks were wobbling as investors take in megacap earnings
- Caterpillar, Merck rise premarket; Pfizer, JetBlue and ZoomInfo fall
- Busy earnings day, Meta reportedly prepares AI chatbot - what's moving markets
- Roivant's $7 billion bowel drug draws major pharma interest
- Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears
- Horizon (HZNP) tumbles on potential FTC lawsuit to block Amgen deal; Analysts surprised
